Insights › Stocks
Biontech (BNTX) News Today
1 headline on Biontech cleared our tape in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% within fifteen minutes. The largest measured reaction was +2.19% on BNTX at Aug 28, 09:15 ET.
Price action when the news broke
BNTX
BioNTech (BNTX) has concluded its Phase 2 clinical trial for colorectal cancer.
MoveSurge publish 09:15:45 ET
MoveSurge publish
09:15:45 ET
106.18
102.93
99.57
96.32
102.48
09:13
09:15
09:32
09:15:45 ET
What moved BNTX — last 7 days
| Time | Headline | 1 min | 15 min | Volume |
|---|---|---|---|---|
| Aug 28, 09:15 ET | BioNTech (BNTX) has concluded its Phase 2 clinical trial for colorectal cancer. | +0.75% | +2.19% | 277k sh |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Times are New York ET.
Our analysis
BioNTech Q2 2026: A 60% Revenue Collapse the Stock Didn't React To
BioNTech reported second-quarter 2026 results on August 4, 2026.
Why Is BioNTech Stock Barely Moving Today?
BioNTech's revenue fell roughly 60% and guidance was cut — but the stock didn't budge, because the market stopped valuing it on COVID vaccine sales a …